Jack, Clifford R. Jr
Knopman, David S.
Chételat, Gaël
Dickson, Dennis
Fagan, Anne M.
Frisoni, Giovanni B.
Jagust, William
Mormino, Elizabeth C.
Petersen, Ronald C.
Sperling, Reisa A.
van der Flier, Wiesje M.
Villemagne, Victor L.
Visser, Pieter J.
Vos, Stephanie J. B.
Article History
First Online: 18 January 2016
Competing interests
: C.R.J.Jr has provided consulting services for Eli Lilly. D.S.K. is on a data safety monitoring board for Lundbeck Pharmaceuticals and is participating in clinical trials sponsored by Lilly Pharmaceuticals and TauRx Pharmaceuticals. A.M.F. has provided consulting services for Eli Lilly, Roche, AbbVie, IBL International and Novartis. W.J. is a consultant to Synarc–Bioclinica and to Banner Alzheimer disease Institute–Genentech. R.C.P. is on a data monitoring committee for Pfizer and Janssen Alzheimer Immunotherapy; is a consultant for Merck, Roche, and Genentech; receives royalties from publishingMild Cognitive Impairment(Oxford University Press, 2003). R.A.S. has been a consultant for Janssen Eisai, Lundbeck, Isis, Boehringer Ingelheim, Roche and Genentech; and receives research support from the Fidelity Biosciences, and Janssen. W.M.v.d.F. has provided consulting services for Boehringer Ingelheim and received research funding from Boehringer Ingelheim; all funds are paid to her institution. V.L.V. has provided consulting services for Bayer Healthcare and Novartis, and has received speaker's honouraria from AstraZeneca, GE Healthcare and Piramal Imaging. P.J.V. has provided consulting services for Bristol–Myers Squibb, Élan–Wyeth, Ipsen, and Roche Diagnostics. G.C. and G.B.F. declare no competing interests.